The impact of previous HBV infection on the course of chronic hepatitis C

American Journal of Gastroenterology

Volumn 95, Issue 12, 2000, Pages 3529-3536

  Cohen, Russell D ^a,b   Tsang, Jennifer F ^a   Hanauer, Stephen B ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b MC 4076 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; RECOMBINANT ALPHA INTERFERON; VIRUS DNA; VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; ANTIVIRAL AGENTS; BIOPSY, NEEDLE; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 0033638459     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02164-X     Document Type: Article

References (35)

1. Hepatitis C virus infection in chronic hepatitis B virus carders
2. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
3. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B
4. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients
5. Clinical and virological profiles in patients with multiple hepatitis virus infections
6. Hepatitis B and C coinfections and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation
7. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment
8. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis
9. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B
10. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B
11. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study
12. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: A prospective study
13. Therapy of chronic active hepatitis C with α-interferon: Effectiveness and prognostic factors
14. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon treated patients with hepatitis C virus chronic hepatitis
15. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection
16. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
17. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
18. High dose interferon alpha-2b therapy for chronic hepatitis C: An open label study of the response and predictors of response
19. Utility of hepatitis C virus RNA determinations in hepatic tissue as an end point for interferon treatment of chronic hepatitis C
20. Dose increase augments response rate to interferon-alpha in chronic hepatitis C
21. Genotypes and genetic variation of hepatitis C virus
22. The complete nucleotide sequences of the cloned hepatitis B virus DNA: Subtype adr and adw
23. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions
24. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carders seropositive for antibody to hepatitis B surface antigen
25. Hepatitis-associated markers in the American Red Cross blood donor population. V. Prevalence of antibodies to core antigen in three blood services regions
26. Evaluation of routine anti-HBc screening of volunteer blood donors: A questionable surrogate test for non-A, non-B hepatitis
27. Characteristics of patients with dual infection by hepatitis B and C viruses
28. New approach to HCV treatment. Recognition of disease process as systemic viral infection rather than as liver disease
29. Response to interferon alpha therapy is influenced by the iron content of the liver
30. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy
31. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C
32. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody M1B1 Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxidation
33. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
34. Role of iron in regulation of virulence genes
35. Iron, iron-binding proteins and immune system cells